WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
-0.99%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$10.4B
AUM Growth
-$393M
(-3.6%)
Cap. Flow
-$94.4M
Cap. Flow
% of AUM
-0.9%
Top 10 Holdings %
Top 10 Hldgs %
14.8%
Holding
711
New
186
Increased
182
Reduced
155
Closed
168
Top Buys
| 1 |
Marsh & McLennan
MMC
|
+$123M |
| 2 |
Electronic Arts
EA
|
+$102M |
| 3 |
Chord Energy
CHRD
|
+$100M |
| 4 |
Quest Diagnostics
DGX
|
+$89.2M |
| 5 |
Sensata Technologies
ST
|
+$73.8M |
Top Sells
| 1 |
Analog Devices
ADI
|
+$138M |
| 2 |
Avnet
AVT
|
+$131M |
| 3 |
ERF
Enerplus Corporation
ERF
|
+$110M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$73.5M |
| 5 |
Amazon
AMZN
|
+$73.3M |
Sector Composition
| 1 | Healthcare | 42.62% |
| 2 | Technology | 19.87% |
| 3 | Energy | 7.88% |
| 4 | Industrials | 7.25% |
| 5 | Financials | 7.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
BellRing Brands
BRBR
$4.51B
| $5.69M | 0.05% |
99,574
+49,703
| +100% | +$2.84M |
|
327
Twilio
TWLO
$16.7B
| $5.63M | 0.05% |
+99,120
| New | +$5.63M |
|
328
Zevra Therapeutics
ZVRA
$468M
| $5.62M | 0.05% |
1,147,583
+137,966
| +14% | +$676K |
|
329
US Physical Therapy
USPH
$1.29B
| $5.54M | 0.05% |
59,951
-4,589
| -7% | -$424K |
|
330
Tencent Music
TME
$38.9B
| $5.3M | 0.05% |
377,064
-274,244
| -42% | -$3.85M |
|
331
Viridian Therapeutics
VRDN
$1.62B
| $5.22M | 0.05% |
400,915
-38,007
| -9% | -$494K |
|
332
Semtech
SMTC
$5.26B
| $5.13M | 0.05% |
171,645
+69,593
| +68% | +$2.08M |
|
333
UroGen Pharma
URGN
$991M
| $5.1M | 0.05% |
+303,740
| New | +$5.1M |
|
334
Shake Shack
SHAK
$3.93B
| $5.09M | 0.05% |
56,569
+831
| +1% | +$74.8K |
|
335
Terns Pharmaceuticals
TERN
$661M
| $5.07M | 0.05% |
+745,044
| New | +$5.07M |
|
336
Cogent Biosciences
COGT
$1.77B
| $5.06M | 0.05% |
600,098
-98,280
| -14% | -$829K |
|
|
OLK
337
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $5.06M | 0.05% |
198,413
-1,473,856
| -88% | -$37.6M |
|
338
Zscaler
ZS
$43.8B
| $5.03M | 0.05% |
26,183
+22,567
| +624% | +$4.34M |
|
339
Recursion Pharmaceuticals
RXRX
$2.05B
| $4.98M | 0.05% |
+664,450
| New | +$4.98M |
|
340
Herbalife
HLF
$1.02B
| $4.91M | 0.05% |
+472,473
| New | +$4.91M |
|
341
Agios Pharmaceuticals
AGIO
$2.1B
| $4.89M | 0.05% |
+113,378
| New | +$4.89M |
|
342
The Beauty Health Co
SKIN
$296M
| $4.8M | 0.05% |
2,502,320
-622,996
| -20% | -$1.2M |
|
343
Akero Therapeutics
AKRO
$3.57B
| $4.7M | 0.04% |
200,432
+71,991
| +56% | +$1.69M |
|
344
Prestige Consumer Healthcare
PBH
$3.24B
| $4.69M | 0.04% |
+68,048
| New | +$4.69M |
|
|
MRNS
345
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $4.66M | 0.04% |
3,979,605
+2,792,824
| +235% | +$3.27M |
|
346
Absci
ABSI
$380M
| $4.54M | 0.04% |
1,475,076
+891
| +0.1% | +$2.74K |
|
347
Editas Medicine
EDIT
$248M
| $4.53M | 0.04% |
970,491
+75,491
| +8% | +$353K |
|
348
Birkenstock
BIRK
$8.99B
| $4.51M | 0.04% |
+82,864
| New | +$4.51M |
|
349
Bausch + Lomb
BLCO
$5.49B
| $4.5M | 0.04% |
309,965
| – | – |
|
|
INZY
350
DELISTED
Inozyme Pharma
INZY
| $4.46M | 0.04% |
1,000,673
+112,606
| +13% | +$502K |
|